Related Experiment Video
Updated: Jul 22, 2026
12:45
Mechanical Stimulation of Chondrocyte-agarose Hydrogels
Published on: October 27, 2012
Sustained modulation of the inflammatory microenvironment for cartilage repair using an ROS-responsive hydrogel
Ming Zhu1, Shimin Dai2, Jingquan Cui3
1Department of Joint Surgery, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, 250021, PR China; Orthopaedic Research Institute, Shandong First Medical University, PR China.
Biomaterials Advances
|July 9, 2026
Summary
This study developed a novel hydrogel delivering engineered exosomes to repair cartilage defects. The smart biomaterial effectively reduced inflammation and promoted significant cartilage regeneration in a rat model, offering a promising osteoarthritis treatment.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Osteoarthritis Research
Background:
- Osteoarthritis (OA) is characterized by chronic inflammation and oxidative stress, hindering cartilage repair.
- Bone marrow mesenchymal stromal cell (BMSC)-derived exosomes show potential for cartilage regeneration but are limited by hostile microenvironments.
- Existing therapies struggle to address the complex pathological factors in OA.
Purpose of the Study:
- To develop a ROS-responsive hydrogel system for controlled delivery of engineered exosomes to enhance cartilage regeneration.
- To investigate the immunomodulatory effects and chondroprotective capabilities of the developed system.
- To evaluate the efficacy of the system in promoting hyaline cartilage-like repair in a rat model of cartilage defects.
Main Methods:
- Engineered exosomes overexpressing CircSERPINE2 were isolated from BMSC.
- A ROS-responsive boronate-vinyl (BV) hydrogel was synthesized using dynamic boronate ester crosslinking.
- The BV hydrogel encapsulated engineered exosomes (BV@cSERPINE2-Exo) for sustained release and microenvironmental modulation.
- In vitro assays assessed macrophage polarization and chondrocyte protection.
- A rat patellar cartilage defect model was used to evaluate in vivo repair efficacy.
Main Results:
- The BV hydrogel demonstrated rapid gelation, injectability, and potent ROS-scavenging.
- BV@cSERPINE2-Exo modulated macrophages from M1 to M2 phenotype and protected chondrocytes from degeneration.
- Intra-articular injection in rats promoted cartilage matrix deposition and near-complete hyaline cartilage-like repair within 8 weeks.
- The engineered exosome-loaded hydrogel significantly outperformed control groups in cartilage repair.
Conclusions:
- The developed ROS-responsive hydrogel platform enables controlled delivery of engineered exosomes for effective cartilage regeneration.
- This strategy integrates immunomodulation and chondroprotection, offering a promising approach for early OA intervention.
- The cell-free biomaterial system presents a viable therapeutic option for cartilage defects and OA progression.
